32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma.
Xiaoyu LiuFang GaoLongwei JiangMeng JiaLei AoMing LuLiming GouMitchell HoShaochang JiaFei ChenWei GaoPublished in: Journal of translational medicine (2020)
Our study provides a rationale for 32A9 as a promising GPC3-specific antibody candidate for HCC immunotherapy.